Trial Profile
Program of vascular evaluation under glucose control by DPP-4 inhibitor.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Mar 2019
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Antihyperglycaemics
- Indications Atherosclerosis
- Focus Therapeutic Use
- Acronyms PROLOGUE
- 01 Feb 2019 Results from an an exploratory post hoc analysis of the PROLOGUE study using subgroups stratified by use of concomitant antidiabetic agents published in the Heart and Vessels
- 15 May 2017 Status changed from active, no longer recruiting to completed.
- 16 Nov 2016 Results of sub analysis assessing effect of sitagliptin on echocardiographic systolic and diastolic parameters and N-terminal pro brain natriuretic peptide, presented at the 89th Annual Scientific Sessions of the American Heart Association